• S&P 500: 1,342.64
  • Change: -0.69%
$3.64 -0.19 (-4.96%)
2/10/2012 4:00 PM

Cytori Therapeutics, Inc. (USA) (NASDAQ:CYTX)

CAPS Rating: 2 out of 5

A developing company which seeks to commercialize stem and regenerative cell therapies for cardiovascular disease, reconstructive surgery and many other serious, chronic, and life threatening conditions.

Current Price $3.64 Mkt Cap $195.82M
Open $3.73 P/E Ratio 0.00
Prev. Close $3.83 Div. (Yield) N/A (N/A)
Daily Range $3.63 - $3.77 Volume 863,449
52-Wk Range $1.90 - $8.44 Avg. Daily Vol. 0

News & Discussion Boards

Caps

How do you think CYTX will perform against the market?

You must Sign in to MSN Caps before you can make a call.

All Players

174 Outperform
29 Underperform
 

All-Star Players

32 Outperform
12 Underperform
 

Wall Street

3 Outperform
0 Underperform
 

Top CYTX Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

zzlangerhans (99.27)
Submitted July 30, 2011

Cytori is a very polarizing stock. Cheerleaders like Zacks point to positive data from clinical trials of adipose-derived regenerative cells in breast reconstruction, and a potential expansion of the technology to restore heart function after… More

Add Comment | Reply | Report this Post

NeroSagetrade (93.97)
Submitted February 12, 2008

What a staggeringly STAGGERINGLY bad company! The numbers are absolutely obstrusive. These guys could write a book on how to lose money and it would be a best seller. Cytori has lost a whopping 52M in the last 2 years and is sitting on less than 30M… More

1 Comment | Reply | Report this Post
CYTX VS S&P 500 (SPY)

Fools bullish on CYTX are also bullish on:

Fools bearish on CYTX are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about CYTX.

Recs

0
Member Avatar vxfrbeva (< 20) Submitted: 2/3/2012 3:20:29 PM : Outperform Start Price: $4.20 CYTX Score: -13.33

Cytori Therapeutics is inmerse in a big moment right now. Their bussines is going to get huge as there is a big market for the stem cells applied to heart recovery after heart atacks and also for the breasts surgery.

Report this Post Add Comment | Reply | Permalink

Recs

0
Member Avatar englishdk (< 20) Submitted: 12/7/2011 7:50:24 AM : Underperform Start Price: $2.57 CYTX Score: -34.86

stem cells dont work

Report this Post Add Comment | Reply | Permalink

Recs

0
Member Avatar wayne094 (< 20) Submitted: 11/16/2011 2:24:31 PM : Outperform Start Price: $2.75 CYTX Score: +25.80

more and more horse trainers and pro sport players arre looking into stem cell its a rocket about to take off.

Report this Post Add Comment | Reply | Permalink
View All 42 Pitches »

Leaderboard

Find the members with the highest scoring picks in CYTX.

Score Leader

vbaci

vbaci (99.42) Score: +143.33

The Score Leader is the player with the highest score across all their picks in CYTX.

Top
Pick 		Member Name Member
Rating 		Start
Date 		Call Time
Frame 		Start
Price 		Stock
Gain 		Index
Gain 		Score Commentary
coenundrum 97.63 1/14/2010 Underperform 5Y $7.99 -54.44% +17.07% +71.51 0 Comment
udlilmike 59.76 2/2/2010 Underperform 1Y $7.04 -48.30% +22.97% +71.27 0 Comment
hedgefund51 < 20 1/13/2010 Underperform NS $7.35 -50.48% +17.91% +68.39 0 Comment
shorttest4 20.78 3/8/2010 Underperform 5Y $7.30 -50.14% +17.59% +67.73 0 Comment
SwingingBridge 69.43 12/11/2009 Underperform 5Y $6.60 -44.85% +20.93% +65.77 0 Comment
smax1980 97.33 12/8/2009 Underperform 5Y $6.14 -40.72% +22.40% +63.12 0 Comment
GoldDontGlitter < 20 12/7/2009 Underperform 5Y $6.23 -41.57% +21.14% +62.72 0 Comment
longtermgrowth09 68.34 12/17/2009 Underperform 5Y $6.14 -40.72% +21.35% +62.07 0 Comment
39272x2 < 20 12/1/2009 Underperform 5Y $6.00 -39.33% +21.13% +60.47 0 Comment
Shizzolator < 20 12/3/2009 Underperform 5Y $6.03 -39.64% +20.45% +60.08 0 Comment
View Complete Scorecard »

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Player Name Player
Rating		 Start
Date		 Call Time
Frame		 Start
Price		 Stock
Gain		 S&P
Gain		 Score End Date Commentary
TrackZacks 71.09 11/11/2008 Outperform 3M $3.01 +20.93% +53.56% -32.63 1 Comment
TrackZacks 71.09 6/24/2008 Outperform 3M $6.78 -35.55% -24.24% -11.31 10/20/2008 @ $4.37 1 Comment
TrackRodmanRen < 20 1/2/2008 Outperform NS $6.23 -5.14% -23.50% +18.37 12/21/2009 @ $5.91 0 Comment
TrackBroadpointAmTech 90.31 12/12/2007 Outperform NS $5.40 -32.59% -6.81% -25.78 0 Comment
TrackStanfordRes 85.38 10/9/2007 Outperform NS $6.32 -42.41% -9.53% -32.87 0 Comment

Featured Broker Partners